HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kenji M Cunnion Selected Research

cobra venom factor

11/2014Complement inhibition significantly decreases red blood cell lysis in a rat model of acute intravascular hemolysis.
6/2004Role of complement receptors 1 and 2 (CD35 and CD21), C3, C4, and C5 in survival by mice of Staphylococcus aureus bacteremia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kenji M Cunnion Research Topics

Disease

8Hemolysis
02/2021 - 11/2011
7Infections
01/2021 - 06/2004
6Inflammation (Inflammations)
01/2021 - 01/2008
4Transfusion Reaction
02/2021 - 01/2016
4Wounds and Injuries (Trauma)
01/2021 - 09/2010
3Acute Lung Injury
01/2022 - 01/2020
3Cystic Fibrosis (Mucoviscidosis)
01/2017 - 01/2015
3Staphylococcal Infections
01/2012 - 07/2008
2Wound Infection (Wound Infections)
01/2018 - 09/2010
2Autoimmune Diseases (Autoimmune Disease)
01/2015 - 11/2010
2Sinusitis
01/2013 - 01/2011
2Communicable Diseases (Infectious Diseases)
11/2012 - 11/2011
2Bacterial Infections (Bacterial Infection)
03/2012 - 01/2011
1Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain)
01/2022
1Hematologic Diseases (Blood Diseases)
01/2022
1Animal Disease Models
01/2022
1Sickle Cell Anemia (Hemoglobin S Disease)
02/2021
1Viral Pneumonia
01/2021
1Transfusion-Related Acute Lung Injury
01/2020
1Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
01/2019
1Hemolytic Anemia
01/2019
1Multiple Trauma (Multiple Injuries)
01/2018
1Surgical Wound Infection
01/2018
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2018
1Lung Diseases (Lung Disease)
01/2017
1HIV Infections (HIV Infection)
01/2016
1Hepatitis C
01/2016
1Coinfection
01/2016
1Acute Kidney Injury (Acute Renal Failure)
01/2016
1Peritonitis
10/2015
1Reinfection
10/2015
1Endocarditis
04/2015
1Infectious Arthritis (Septic Arthritis)
04/2015
1Hypothermia
06/2014
1Reperfusion Injury
06/2014
1Hereditary Angioedemas
01/2014
1Hyperglycemia
01/2014
1Abscess
01/2013
1Renal Insufficiency (Renal Failure)
11/2011
1Lyme Disease (Disease, Lyme)
11/2011
1Autoimmune Hemolytic Anemia (Cold Agglutinin Disease)
11/2011
1Pyelonephritis
01/2011
1Pneumonia (Pneumonitis)
01/2011
1Urinary Tract Infections (Urinary Tract Infection)
01/2011
1Gastroenteritis
01/2008

Drug/Important Bio-Agent (IBA)

20Complement System Proteins (Complement)IBA
01/2022 - 06/2004
7Peptides (Polypeptides)IBA
01/2022 - 01/2016
5Complement C1 (Complement 1)IBA
01/2021 - 01/2016
3Anti-Bacterial Agents (Antibiotics)IBA
01/2018 - 09/2010
3AnaphylatoxinsIBA
01/2017 - 06/2004
2RLS-0071IBA
01/2022 - 01/2021
2BuffersIBA
02/2021 - 01/2016
2DNA (Deoxyribonucleic Acid)IBA
01/2020 - 01/2017
2Ceftriaxone (Ceftriaxon)FDA LinkGeneric
01/2019 - 11/2011
2Peroxidase (Myeloperoxidase)IBA
01/2017 - 01/2017
2Immunoglobulin G (IgG)IBA
01/2016 - 01/2014
2cobra venom factorIBA
11/2014 - 06/2004
2Levofloxacin (Levaquin)FDA Link
01/2011 - 09/2010
1Complement Inactivating AgentsIBA
02/2021
1Acyclovir (Aciclovir)FDA LinkGeneric
01/2021
1Antiviral Agents (Antivirals)IBA
01/2021
1NucleosidesIBA
01/2021
1LipopolysaccharidesIBA
01/2020
1AntibodiesIBA
01/2020
1Antigen-Antibody Complex (Immune Complex)IBA
01/2018
1Terbinafine (Lamisil)FDA LinkGeneric
01/2018
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2017
1Leukocyte Elastase (Neutrophil Elastase)IBA
01/2017
1Hypochlorous Acid (Hypochlorite)IBA
01/2017
1VaccinesIBA
01/2017
1CCR2 ReceptorsIBA
01/2017
1EnzymesIBA
01/2017
1Barbital (Barbitone)IBA
01/2016
1Hemoglobins (Hemoglobin)IBA
01/2016
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2016
1Intravenous Immunoglobulins (IVIG)FDA Link
01/2016
1factor AIBA
04/2015
1Fibrinogen (Factor I)FDA Link
04/2015
1ApolipoproteinsIBA
04/2015
1Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA
01/2014
1KininsIBA
01/2014
1VancomycinFDA LinkGeneric
01/2013
1Rifampin (Rifampicin)FDA LinkGeneric
01/2013
1Pharmaceutical PreparationsIBA
11/2011
1Doxycycline (Periostat)FDA LinkGeneric
11/2011
1LectinsIBA
11/2010
1chlorhexidine gluconate (Dyna-Hex)FDA LinkGeneric
09/2010
1SilverIBA
09/2010
1Tobramycin (Nebcin)FDA LinkGeneric
09/2010
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
09/2010
1Anti-Infective Agents (Microbicides)IBA
09/2010
1Biological ProductsIBA
01/2008
1Complement Receptors (Complement Receptor)IBA
06/2004

Therapy/Procedure

5Therapeutics
01/2018 - 01/2011
1Critical Care (Surgical Intensive Care)
02/2021
1Blood Transfusion (Blood Transfusions)
01/2021
1Erythrocyte Transfusion
01/2020
1Peritoneal Dialysis
10/2015
1Induced Hypothermia
06/2014
1Debridement
01/2012